Menu
Recruiting NCT07571538

VisionApp - Ghosting

No phase Interventional Diplopia, Monocular

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Proclear 1 Day Contact Lens, MyDay Contact Lens, NaturalVue Contact Lens, MiSight 1 Day Contact Lens.
Who it may be relevant to
Registry conditions: Diplopia, Monocular. Basic parameters: from 8 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Assessment of the Accuracy and Repeatability of the VisionApp - Ghosting Measurement Protocol

Overview

Recent Android mobile device technology is available which allows user-measured refractive error and reading add power. This technology could be quite useful to the clinical and research community. The current study aims to evaluate the accuracy, repeatability, and reproducibility of one such technology by VisionApp, specifically with regard to ghosting vision. VisionApp is an app which runs on a smartphone or other device which uses the distance between the user's face and the phone to determine refractive error, while the user looks at different targets (lines, letters, words, etc).

Detailed description

Subjects will be enrolled at the Clinical Optics Research Lab at Indiana University.

At the study visit, demographic and health/ocular history may be collected by oral history and standard clinical testing including refraction (check of glasses prescription), auto-refraction or abbrerometry may be performed. Visual acuity and room lighting checks may also be measured using standard clinical techniques.

For the experimental portion of the study visit, participants will be asked to look at letters and describe any shadows or distortions they see using slider bars or numerical rating scales, while wearing different contact lenses. Participants will first be asked to wear commercially available single vision contact lenses to establish best corrected vision. A single vision lens will then remain in one eye, and participants will proceed with ghosting assessments using two different multifocal contact lenses worn in the other eye. Adult participants will perform the ghosting assessments while wearing 2 commercially available multifocal lenses, and children participants will perform the ghosting assessments while wearing a commercially available and investigational lens. Randomization will determine which lens is worn first.

If participants are unable to complete all testing in a single session, they may be permitted to return on a subsequent day.

Interventions

  • Device Proclear 1 Day Contact Lens
    Proclear 1 day is a commercially available single vision soft contact lens for single use (daily wear). Participants will wear these contacts at the beginning of the study visit to establish best corrected vision. Participants will then continue to wear this contact lens in one eye for the duration of the study visit.
  • Device MyDay Contact Lens
    MyDay is a commercially available multifocal soft contact lens for daily wear. Adult participants will assess images for ghosting while wearing a MyDay contact lens in one eye. Order of exposure to this lens will be determined via randomization.
  • Device NaturalVue Contact Lens
    NaturalVue is a commercially available multifocal soft contact lens for daily wear. Adult participants will assess images for ghosting while wearing a NaturalVue contact lens in one eye. Order of exposure to this lens will be determined via randomization.
  • Device MiSight 1 Day Contact Lens
    MiSight 1 Day is a commercially available multifocal soft contact lens for daily wear. Children participants will assess images for ghosting while wearing a MiSight 1 Day contact lens in one eye. Order of exposure to this lens will be determined via randomization.
  • Device Investigational Contact Lens
    An investigational multifocal soft contact lens for daily wear. While the contact lens is made of an FDA approved material which is already marketed in the United States, it differs from commercially available lenses in that it has a slightly different optical design. Children participants will assess images for ghosting while wearing this investigational contact lens in one eye. Order of exposure to this lens will be determined via randomization.
  • Device VisionApp
    VisionApp is an app which runs on a smartphone or other device which uses the distance between the user's face and the phone to determine refractive error, while the user looks at different targets (lines, letters, words, etc.)

Primary outcome measures

  • Ghosting Quantification [Time frame: Day 1]

Eligibility criteria

Inclusion criteria

  • has a refractive error between Plano and -5.00 D of sphere and cylinder components combined.
  • has refractive cylinder (e.g., astigmatism) of -0.75 D or less
  • has had a self-reported oculo-visual exam in the last 2 years
  • has best-corrected visual acuity of at least 20/20 in each eye
  • is not amblyopic or does not have any diagnosed ocular disease
  • is willing and able to follow instructions and maintain the appointment schedule

Exclusion criteria

  • has any systemic disease affecting ocular health and visual acuity
  • is currently using any systemic or topical medications that could affect ocular health and visual acuity
  • is participating in another eye related research study

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Crossover
Masking
Open label
Primary purpose
Diagnostic

Study locations

United States · 1 center
  • Clinical Optics Research Lab — Bloomington

Identifiers

NCT: NCT07571538 · 12501b

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗